Health Catalyst to Announce Fourth Quarter and Full Year 2023 Operating Results and Host Conference Call on Thursday, February 22, 2024
08 Fevereiro 2024 - 10:00AM
Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading
provider of data and analytics technology and services to
healthcare organizations, will release its fourth quarter and full
year 2023 operating results on Thursday, February 22, 2024, after
market close. In conjunction, the company will host a conference
call to review the results at 5 p.m. E.T. on the same day.
Conference Call Details
The conference call can be accessed by dialing 800-267-6316 for
U.S. participants, or 203-518-9783 for international participants,
and referencing conference ID “HCAT Q423.” A live audio webcast
will be available online at https://ir.healthcatalyst.com/. A
replay of the call will be available via webcast for on-demand
listening shortly after the completion of the call, at the same web
link, and will remain available for approximately 90 days.
About Health Catalyst
Health Catalyst is a leading provider of data and analytics
technology and services to healthcare organizations committed to
being the catalyst for massive, measurable, data-informed
healthcare improvement. Its customers leverage the cloud-based data
platform—powered by data from more than 100 million patient records
and encompassing trillions of facts—as well as its analytics
software and professional services expertise to make data-informed
decisions and realize measurable clinical, financial, and
operational improvements. Health Catalyst envisions a future in
which all healthcare decisions are data informed.
Health Catalyst Investor Relations Contact:
Adam BrownSenior Vice President, Investor Relations and
FP&A+1 (855)-309-6800ir@healthcatalyst.com
Health Catalyst Media Contact:
Tarah Neujahr BryanChief Marketing
Officermedia@healthcatalyst.com
Health Catalyst (NASDAQ:HCAT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Health Catalyst (NASDAQ:HCAT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024